Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CASD1 | Human | (+)-schisandrin B | multiple interactions | ISO | Casd1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CASD1 mRNA] | CTD | PMID:31150632 | CASD1 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CASD1 mRNA | CTD | PMID:22079256 | CASD1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Casd1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CASD1 mRNA | CTD | PMID:36331819 | CASD1 | Human | 1,1-dichloroethene | decreases expression | ISO | Casd1 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of CASD1 mRNA | CTD | PMID:26682919 | CASD1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Casd1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CASD1 mRNA | CTD | PMID:22206623 | CASD1 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CASD1 mRNA | CTD | PMID:21453500 | CASD1 | Human | 17beta-estradiol | decreases expression | ISO | Casd1 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of CASD1 mRNA | CTD | PMID:32145629 | CASD1 | Human | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of CASD1 mRNA | CTD | PMID:29581250 | CASD1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Casd1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CASD1 mRNA | CTD | PMID:19465110 | CASD1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CASD1 mRNA | CTD | PMID:20106945 and PMID:21632981 | CASD1 | Human | 5-fluorouracil | affects expression | ISO | Casd1 (Mus musculus) | 6480464 | Fluorouracil affects the expression of CASD1 mRNA | CTD | PMID:20421339 | CASD1 | Human | all-trans-retinoic acid | affects expression | ISO | Casd1 (Mus musculus) | 6480464 | Tretinoin affects the expression of CASD1 mRNA | CTD | PMID:20421339 | CASD1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of CASD1 mRNA | CTD | PMID:33212167 | CASD1 | Human | benzo[a]pyrene | increases methylation | ISO | Casd1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of CASD1 exon and Benzo(a)pyrene results in increased methylation of CASD1 intron | CTD | PMID:27901495 | CASD1 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of CASD1 promoter | CTD | PMID:27901495 | CASD1 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | CASD1 | Human | bisphenol A | affects expression | ISO | Casd1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CASD1 mRNA | CTD | PMID:25181051 | CASD1 | Human | bleomycin A5 | decreases expression | EXP | | 6480464 | bleomycetin results in decreased expression of CASD1 mRNA | CTD | PMID:21040473 | CASD1 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of CASD1 mRNA | CTD | PMID:26079696 | CASD1 | Human | carbon nanotube | decreases expression | ISO | Casd1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CASD1 | Human | chlorpyrifos | decreases expression | ISO | Casd1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CASD1 mRNA | CTD | PMID:37019170 | CASD1 | Human | cobalt dichloride | decreases expression | ISO | Casd1 (Rattus norvegicus) | 6480464 | cobaltous chloride results in decreased expression of CASD1 mRNA | CTD | PMID:24386269 | CASD1 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CASD1 mRNA | CTD | PMID:19549813 | CASD1 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CASD1 mRNA | CTD | PMID:25562108 | CASD1 | Human | dibutyl phthalate | increases expression | ISO | Casd1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of CASD1 mRNA | CTD | PMID:21266533 | CASD1 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of CASD1 mRNA | CTD | PMID:28302478 | CASD1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CASD1 mRNA | CTD | PMID:27188386 | CASD1 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CASD1 mRNA | CTD | PMID:29803840 | CASD1 | Human | folic acid | decreases expression | ISO | Casd1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CASD1 mRNA | CTD | PMID:25629700 | CASD1 | Human | gentamycin | decreases expression | ISO | Casd1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of CASD1 mRNA | CTD | PMID:33387578 | CASD1 | Human | hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CASD1 mRNA | CTD | PMID:17183730 | CASD1 | Human | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of CASD1 mRNA | CTD | PMID:24449571 | CASD1 | Human | methoxyacetic acid | affects expression | ISO | Casd1 (Mus musculus) | 6480464 | methoxyacetic acid affects the expression of CASD1 mRNA | CTD | PMID:20421339 | CASD1 | Human | Monobutylphthalate | affects expression | ISO | Casd1 (Mus musculus) | 6480464 | monobutyl phthalate affects the expression of CASD1 mRNA | CTD | PMID:20421339 | CASD1 | Human | p-toluidine | decreases expression | ISO | Casd1 (Rattus norvegicus) | 6480464 | 4-toluidine results in decreased expression of CASD1 mRNA | CTD | PMID:27638505 | CASD1 | Human | paracetamol | affects expression | ISO | Casd1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CASD1 mRNA | CTD | PMID:17562736 | CASD1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Casd1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CASD1 mRNA | CTD | PMID:36331819 | CASD1 | Human | phenobarbital | decreases expression | ISO | Casd1 (Rattus norvegicus) | 6480464 | Phenobarbital results in decreased expression of CASD1 mRNA | CTD | PMID:28520973 | CASD1 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of CASD1 mRNA | CTD | PMID:22079256 | CASD1 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CASD1 mRNA | CTD | PMID:22079256 | CASD1 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CASD1 mRNA | CTD | PMID:21632981 | CASD1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CASD1 mRNA | CTD | PMID:27188386 | CASD1 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CASD1 mRNA | CTD | PMID:34032870 | CASD1 | Human | tetrachloromethane | decreases expression | ISO | Casd1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of CASD1 mRNA | CTD | PMID:31150632 | CASD1 | Human | tetrachloromethane | multiple interactions | ISO | Casd1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CASD1 mRNA] | CTD | PMID:31150632 | CASD1 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of CASD1 mRNA | CTD | PMID:24935251 | CASD1 | Human | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of CASD1 mRNA | CTD | PMID:28542535 | CASD1 | Human | trovafloxacin | multiple interactions | ISO | Casd1 (Mus musculus) | 6480464 | [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in decreased expression of CASD1 mRNA | CTD | PMID:18930950 | CASD1 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CASD1 mRNA more ... | CTD | PMID:17183730 and PMID:27188386 | CASD1 | Human | valproic acid | affects expression | ISO | Casd1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of CASD1 mRNA | CTD | PMID:20421339 | CASD1 | Human | valproic acid | decreases expression | ISO | Casd1 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of CASD1 mRNA | CTD | PMID:20546886 and PMID:21427059 | CASD1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CASD1 mRNA | CTD | PMID:25979313 | CASD1 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CASD1 mRNA | CTD | PMID:23179753 more ... | |